van den Hoogen F H, Boerbooms A M, van de Putte L B
Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
Clin Rheumatol. 1990 Sep;9(3):319-24. doi: 10.1007/BF02114391.
We reviewed studies concerning immunomodulating therapy in systemic sclerosis. These comprise mostly uncontrolled trials and case reports. Some of these studies hint at a possible beneficial effect of antimetabolites (azathioprine, 5-fluoro-uracil and methotrexate), cyclosporine and interferon-gamma. However, to give a clearcut answer on the efficacy of these drugs in systemic sclerosis, controlled studies are urgently needed.
我们回顾了关于系统性硬化症免疫调节治疗的研究。这些研究大多为非对照试验和病例报告。其中一些研究暗示抗代谢药物(硫唑嘌呤、5-氟尿嘧啶和甲氨蝶呤)、环孢素和干扰素-γ可能具有有益效果。然而,要明确这些药物在系统性硬化症中的疗效,迫切需要进行对照研究。